Verapamil Hydrochloride

ANDA 90529, held by Sun Pharm Inds Inc. Verapamil Hydrochloride.

As of Nov 15, 2026, ANDA 90529 (Verapamil Hydrochloride), held by Sun Pharm Inds Inc, was first approved by FDA on Dec 30, 2011, with 2 approved supplements and 0 published complete response letters.

First approved: Dec 30, 2011
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Dec 30, 2011	Original application	Approved	None posted

Products

3 strengths and forms


Verapamil Hydrochloride120MG · tablet, extended release;oral	Verapamil Hydrochloride	Discontinued
Verapamil Hydrochloride180MG · tablet, extended release;oral	Verapamil Hydrochloride	Discontinued
Verapamil Hydrochloride240MG · tablet, extended release;oral	Verapamil Hydrochloride	Discontinued

All 3 submissions, including labeling and manufacturing supplements


Sep 24, 2019	Supplement 11Labeling · Standard review	Approved	None posted
Sep 24, 2019	Supplement 13Labeling · Standard review	Approved	None posted
Dec 30, 2011	Original application	Approved	None posted

Identifiers

Application: ANDA 90529
Drugs@FDA: Overview at FDA
Company: Sun Pharmaceutical Industries

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters